HUNTER GLASGOW: Open Payments
NPI 1942856232 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 19 payments from 12 companies in 2025. Trend: 2023 $741 · 2024 $336 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 3 | $77 |
| Amgen Inc. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $38 |
| Exact Sciences Corporation | 2 | $33 |
| Novo Nordisk Inc | 2 | $32 |
| Insulet Corporation | 1 | $27 |
| Tandem Diabetes Care, Inc. | 1 | $26 |
| ABBVIE INC. | 1 | $25 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Abbott Laboratories | 1 | $21 |
Products named: GEMTESA, JARDIANCE, Cologuard Collection Kit, Omnipod, t:slim X2 Insulin Pump with Control-IQ, UBRELVY, ELIQUIS, FREESTYLE LIBRE 3.
Industry payments across NC — which companies pay providers there.
